IMAX Corporation (IMAX) saw its shares plunge 5.02% in intraday trading, despite reporting strong second-quarter results that beat estimates. The company's stock took a hit after Goldman Sachs maintained its Sell rating, overshadowing positive analyst reports from other firms.

IMAX's Q2 performance was impressive, with domestic box office significantly outpacing the overall North American market and increased global market share. Wedbush noted that both box office share gains and installations drove the beat, with IMAX ahead of its installation guidance for the year. This positive news led several analysts to raise their price targets, with Seaport Research increasing its target to $38 from $31 and Wells Fargo raising its target to $34 from $30.

However, the optimism was tempered by Goldman Sachs analyst Stephen Laszczyk, who maintained a Sell rating on IMAX with a price target of $18. This bearish stance, possibly due to overvaluation and cash flow concerns, appears to have spooked investors, leading to the sharp decline in IMAX's stock price. The contrast between strong quarterly results and the stock's performance highlights the impact of conflicting analyst opinions on investor sentiment in the short term.